47 results about "Tissue ingrowth" patented technology

Embodiments described herein relate to a support device configured to provide tissue support, during implant-based breast surgery. Embodiments described herein include a matrix sheet disposed in a foldable sheet including one or more templates including at least one of a partial support template and a full support template. The partial support template is configured for use in shaping the matrix sheet into a support device for partial coverage for a breast prosthesis. The full support template is configured for use in shaping the matrix sheet into a support device for full coverage for a breast prosthesis. In some embodiments, the support device is a bioabsorbable mesh substrate, a bioabsorbable polymer coating, and one or more active pharmaceutical agents for delivery at the surgical site. The support device may be provided in various shapes for coverage of the breast prosthesis or provided with templates for various coverage of the breast prosthesis. The support device forms a macroporous scaffold, and the macroporous scaffold may act as a lattice for new tissue ingrowth.

Systems and methods for implanting a shunt for regulating blood pressure between a patient's left and right atria are provided. The shunt comprises an anchor having a neck region, first and second end regions, and a conduit affixed with the anchor formed of a biocompatible material that is resistant to transmural and translation tissue ingrowth and that reduces a risk of paradoxical embolism. The shunt may be advanced through the sheath until the first region protrudes from the sheath and self-expands within the left atrium. The shunt and the sheath may then be retracted until the first region contacts the left side of the atrial septum. The sheath may further be retracted until the counterforce exerted by shunt tension on the atrial septum overcomes the friction of the retained portions of the shunt such that the second region is exposed from the sheath and self-expands within the second atrium.

The present application relates to a kind of nasal ala base subperiosteal implant retention method, belong to plastic surgery medical instrument technical field.The present application provides a kind of nasal ala base subperiosteal implant soft tissue suspension retention method and its implant and system.The method includes: implant is placed into maxillary bone subperiosteal interstice, and implant fixed wing is fixed with the soft tissue anchor point such as alar base ligament of alar elevating lip muscle using drug-loaded degradable suture and is suspended and fixed.Implant surface is provided with the microporous structure of guiding tissue ingrowth, and is provided with the drug depot recess of filling load immunomodulator temperature-sensitive hydrogel.Postoperative healing process, suture is released under the action of tension to accelerate proangiogenic factor and promote local vascularization, and temperature-sensitive hydrogel slow-release immunomodulator induces macrophage to repair type polarization, and cooperatively promotes the biological chimeric fixation of implant and soft tissue.The present application can realize the double stable retention of implant, reduces postoperative displacement risk.

Devices, systems, and / or methods can provide compliance characteristics to fluid vessels. For example, an implant device can include an anchoring region to anchor the implant device to a blood vessel or other anatomy. The anchoring region can be disposed at one end of a flexible midsection that is configured to expand as a result of fluid flowing through the implant device. The flexible midsection can include another anchoring region at an opposite end. One or both anchoring regions are configured to encourage tissue ingrowth at an outer surface of the respective anchoring region.

Disclosed herein is an implantable prosthetic valve that is configured to substantially reduce vascular nebula formation and / or uncontrolled tissue ingrowth along the implantable prosthetic valve. Methods of making such implantable prosthetic valves are also disclosed herein. Also disclosed herein are kits comprising one or more sutures configured to substantially reduce vascular nebula formation and / or uncontrolled tissue ingrowth along the implantable prosthetic valve.

In some embodiments, a dressing can include a treatment device configured with a central hub and a plurality of legs extending outwardly from the central hub. In some embodiments, the central hub and the legs can collectively constitute a treatment manifold configured to minimize tissue ingrowth. For example, the treatment manifold can include closed cell foam. In some embodiments, the treatment manifold can be unencapsulated. For example, a single film layer can be attached to a first surface of the treatment manifold, while an opposite surface of the manifold can be exposed and / or uncovered. Other devices, dressings, systems, and methods are also disclosed.

A balloon-expandable prosthetic heart valve includes a collapsible and expandable stent comprising a plurality of commissure attachment features, and a valve assembly coupled to the collapsible and expandable stent, the valve assembly comprising a plurality of leaflets, an outer cuff configured to promote tissue ingrowth and an inner cuff having an inner surface and an outer surface, the inner surface of the inner cuff having a different ingrowth profile than the outer surface of the inner cuff.

Nonwoven resorbable pouches that at least partially enclose implantable medical devices and improved methods for producing the implantable medical device pouches are described. The nonwoven pouches may comprise one or more drugs. Implantable medical devices that are placed in the pouches prior to implantation are prevented from migrating from the site of implantation by tissue ingrowth into the pouch. Antibiotics may be incorporated into the pouches to prevent post-operative infections. The pouches may be formed in fewer steps than conventional pouches, and without polymer coatings. Nonwoven pouches can be formed in one step by dry spinning instead of using multiple processing steps. In embodiments, the nonwoven pouches are smoother on the inside than the outside to tightly fit the implantable medical devices internally while encouraging external tissue ingrowth. In embodiments, the nonwoven pouches eliminate the use of knitted or woven multifilament fibers that can trap bacteria and result in post-operative infection.

The application discloses a kind of for hernia repair containing acellular dermis biological patch and preparation method thereof, belong to biomedical material field, raw material includes acellular porcine dermis layer matrix 90-110 parts, genipin 0.1-0.2 parts, EDC 0.8-2.5 parts, NHS 0.3-1 part, carboxymethyl chitosan 3-8 parts, sodium hyaluronate 1.5-4 parts, chondroitin sulfate 0.5-2 parts, glycerol 2-5 parts, modified zinc tannate nanocomposite 3-12 parts, effectively solve the problems that existing hernia repair patch anti-adhesion and tissue ingrowth is difficult to coordinate, support strength and degradation rate are not matched, foreign body exists in human tissue for a long time and leads to inflammation, by introducing anti-adhesion coating containing zinc tannate coordination nanocomposite and asymmetric double-sided structure, the patch realizes abdominal cavity side long-acting anti-adhesion, abdominal wall side rapid tissue integration and controllable degradation and mechanical support under low immunogenicity.

Fixation devices for implants and related methods are generally described. The fixation device may be wrapped around the implant prior to delivery to reduce the risk of implant migration after implantation. The device may have porosity to induce tissue ingrowth around the implant and improve surgical outcome. The device can be used for rapidly preparing implants and can adapt to implants of various sizes. In some embodiments, the device may include a central portion for covering an anterior surface of a breast implant and a peripheral portion for covering a posterior surface of the implant. The peripheral portion, which may include a continuous rim or a plurality of legs, may include a tab that secures the fixation device to an implantation site. In some embodiments, a tether may be coupled to a distal end portion of the peripheral portion, thereby serving as a pull cord that quickly wraps the device around the implant.

Implementations of palatal implants may include a core having a plurality of air jet textured core yarns, eight triaxial yarns coupled around the core and parallel to the core, wherein each of the eight triaxial yarns are air jet textured and have a plurality of looped filaments, 24 biaxial yarns braided around the core in a one over one under one pattern, a first weld offset from a first end of the palatal implant by 0.8 millimeters to 1.2 millimeters, and a second weld offset from a second end of the palatal implant by 0.8 millimeters to 1.2 millimeters. The looped filaments in the triaxial yarns may protrude through openings between the biaxial yarns, the palatal implant may have a total braid weight of 7,000 denier to 12,500 denier, and the palatal implant may be configured to stiffen a palate through tissue ingrowth into the palatal implant.

The invention relates to the technical field of surgical drainage, in particular to a drainage device and method used after general surgery department nursing operation, the drainage device comprises a drainage tube and a rack, a drainage boosting assembly is arranged on the inner wall of the drainage tube, and the drainage boosting assembly comprises a plurality of clamping grooves formed in the outer wall of the drainage tube at equal intervals; wave air bag ring assemblies are arranged on the inner sides of the multiple clamping grooves, each wave air bag ring assembly comprises a first annular air bag and an eleventh annular air bag which are sequentially arranged in the corresponding clamping groove in a sleeved mode, and air cavities are formed in the first annular air bags and the eleventh annular air bags, so that harmonious peristaltic waves can be generated for the drainage tube; the drainage effect of the drainage tube is improved, the hole distance of the side holes can be adjusted in real time according to the postoperative drainage condition, tissue ingrowth is effectively prevented, early soft blockage is relieved, the drainage environment is further disturbed, static attachment is prevented, and the overall drainage efficiency and quality of the device are guaranteed.

Dressings are provided herein having a manifold and a biopolymer layer. The configuration and / or compressibility of the manifold and the biopolymer layer can allow for reduced tissue ingrowth and promote wound healing. Methods of making and using the dressings are also provided herein.

A biliary stent includes an expandable stent body that is expandable from a pre-deployment collapsed configuration to a post-deployment expanded configuration and a spun coating that is disposed over at least part of the expandable stent body. The spun coating includes a plurality of fibers defining interstices therebetween. The spun coating is adapted to impact tissue ingrowth. The spun coating may be adapted to encourage tissue ingrowth. The spun coating may be adapted to discourage tissue ingrowth.

Nonwoven resorbable pouches that at least partially enclose implantable medical devices and improved methods for producing the implantable medical device pouches are described. The nonwoven pouches may comprise one or more drugs. Implantable medical devices that are placed in the pouches prior to implantation are prevented from migrating from the site of implantation by tissue ingrowth into the pouch. Antibiotics may be incorporated into the pouches to prevent post-operative infections. The pouches may be formed in fewer steps than conventional pouches, and without polymer coatings. Nonwoven pouches can be formed in one step by dry spinning instead of using multiple processing steps. In embodiments, the nonwoven pouches are smoother on the inside than the outside to tightly fit the implantable medical devices internally while encouraging external tissue ingrowth. In embodiments, the nonwoven pouches eliminate the use of knitted or woven multifilament fibers that can trap bacteria and result in post-operative infection.

The invention provides a multilayer artificial skin flap containing a built-in nutritional blood vessel and a preparation method of the multilayer artificial skin flap, and belongs to the technical field of tissue engineering and regenerative medicine. The artificial skin flap is sequentially provided with a first decellularized meat pulp matrix layer, a nutritional blood vessel, a fabric layer and a second decellularized meat pulp matrix layer from top to bottom. The nutrition blood vessel can construct a nutrition delivery channel for surrounding tissues, and promote rapid proliferation of cells and formation of a new blood vessel network; the decellularized meat pulp matrix layer provides a bionic microenvironment and supports cell adhesion, migration and growth; the fabric layer plays a role in enhancing mechanical support and simultaneously endows the flap with good stitchability and tear resistance; in addition, the nutritional blood vessel and the fabric layer are both made of degradable filaments, the degradation period can be regulated and controlled according to needs, and space and mechanical support smooth transition is vacated for tissue growth. The artificial skin flap has excellent biocompatibility, controllable degradability, active vascularization ability and proper mechanical properties, and is suitable for full-thickness skin defect repair and soft tissue regeneration engineering.

An implantable prosthesis for repairing tissue defects includes a layer of repair fabric and a plurality of microtextured grip segments mounted to the repair fabric. The grip segments include a pattern of perforations on a tissue facing surface to promote tissue ingrowth.

A self-expanding stent configured to shift between a delivery configuration and a deployed configuration, the self-expanding stent including a tubular body having a proximal end and a distal end. In embodiments, the tubular body of the self-expanding stent defines a proximal flange, a distal flange, and a saddle portion extending from the proximal flange to the distal flange. The proximal flange and / or the distal flange may include an open-cell foam material affixed adjacent to or within the proximal flange and / or the distal flange to promote tissue ingrowth therein. Additional flanges, flange orientations, materials, and disposition of materials for a self-expanding stent are also contemplated.

Self-expanding, tubular (tapered or constant diameter), oval or elliptical (not circular) airway stents suitable for placement under open or minimally invasive approaches within patients of various sizes and of various species, and methods for their placement in a tracheobronchial tree of a patient. The airway stent may be provided in various lengths and have an oval or elliptical cross-sectional shape that is either constant or variable in both short axis dimensions. The airway stents are particularly suited for treating patients with large airway obstructions in whom the natural airway cross-sectional dimensions are oval or elliptical rather than circular. The airway stent allows for more anatomic filling of the natural airway lumen, reduces the need to oversize the airway stent diameter and therefore reduces subsequent stent fatigue and fracture, and improves stent-tracheal wall contact to minimize gaps that lead to mucus trapping and chronic infections with subsequent tissue ingrowth and airway obstruction.

Blood flow affecting implant and implantation thereof in superior vena cava, optionally including disintegration of endothelium layer and inducing tissue ingrowth within implant. Implant includes elongated body with optional tubular inner layer forming orifice, shapeable to final orifice diameter for restricting blood flowing therethrough to chosen average flow rate; and / or tubular outer layer provided coaxially around inner layer. Outer layer is formed of second material provided in elastically deformable state for facilitating elastic radial self-expanding from collapsed diameter up to relaxed maximal expanded diameter greater than diameter of inner wall portion of superior vena cava. Inner layer is formed of first material, in plastically or elastically deformable state.

To provide a vascular graft which does not hinder the ingrowth of tissue and which allows the ingrowing tissue layer to adhere to the inner surface.SOLUTION: A method of manufacturing a tubular graft may comprise the steps of: providing a textile comprising a tubular wall disposed between a first open end and an opposed second open end, an inner surface and an opposed outer surface defining an interior wall portion therebetween, the tubular wall comprising a textile construction of one or more filaments or yarns, the textile construction by itself being permeable to liquid; applying a substantially water-soluble material to at least a portion of the tubular wall; and applying a substantially water-insoluble sealant to at least a part of the outer surface of the tubular wall, the substantially water-insoluble sealant being configured to mitigate movement of fluid through the wall of the conduit. The water-soluble material is configured to mitigate penetration of the sealant to the inner surface of the conduit.SELECTED DRAWING: Figure 1c

To provide a breast implant fixation device used in breast reconstruction and augmentation surgery.SOLUTION: New wrap is designed to avoid lateral displacement and being the lowest position of breast implants, reduce capsular contraction and extrusion of the implants, eliminate skin dimpling and wrinkles caused by the breast implants, and reduce or eliminate easy perception. The wrap is adapted to be folded tightly around the breast implants so as to limit relative movement between the wrap and the breast implants and reduce wrinkles. Tissue ingrowth into the wrap limits movement of the wrap-breast implant assembly, thereby limiting movement of the breast implants.SELECTED DRAWING: Figure 4

This application provides a method for preparing decellularized pericardium, employing a combination of specific pretreatment, sterilization, defatting, decellularization, and freeze-drying processes. This method effectively removes antigenic substances from animal tissues while maximally preserving the integrity of bioactive components and structures in the material. Simultaneously, the preparation process effectively incorporates inorganic metal ions, polysaccharides, and drugs to prevent adhesions. The resulting decellularized pericardium possesses both natural rough and smooth surfaces. The smooth surface has a dense fibrous structure, effectively blocking the invasion of adhesion tissues without affecting tendon function. The rough surface allows tissue ingrowth, facilitating rapid vascularization and tendon repair. Furthermore, the decellularized pericardium is loaded with functional components, further promoting tendon healing and preventing adhesions.

An orthopedic assembly includes a tibial prosthesis that includes a body that defines an anterior side and a posterior side. The body further incudes a recess in the anterior side of the joint prosthesis and a plurality of openings that extend through the body from the anterior side to the posterior side thereof. At least a first and second opening of the openings are positioned at respective lateral and medial sides of a longitudinal axis of the tibial prosthesis. A modular insert is positioned within the recess of the body such that at least a portion of the modular insert is positioned between the openings of the body. The modular insert is formed separately from the tibial prosthesis and has a porous outer surface to promote tissue ingrowth.

An orthopedic assembly includes a tibial prosthesis that includes a body that defines an anterior side and a posterior side. The body further incudes a recess in the anterior side of the joint prosthesis and a plurality of openings that extend through the body from the anterior side to the posterior side thereof. At least a first and second opening of the openings are positioned at respective lateral and medial sides of a longitudinal axis of the tibial prosthesis. A modular insert is positioned within the recess of the body such that at least a portion of the modular insert is positioned between the openings of the body. The modular insert is formed separately from the tibial prosthesis and has a porous outer surface to promote tissue ingrowth.

A cardiac support device comprising an implant with a shell (21), wherein the cardiac support device is an active cardiac support device comprising at least one expandable unit (23), wherein the shell (21) has a structured surface (22) that promotes tissue ingrowth, wherein the structured surface is located on the outer, non-cardiac surface of the shell, and wherein the tissue-stiffened shell (21) forms a support for the at least one expandable unit (23).

A composite material is disclosed including a porous polymer substrate and a nanoporous metal present within the microporous polymer substrate. The nanoporous metal may have a hierarchical structure. The nanoporous metal may have a unimodal and right-skewed number-based nanopore size distribution. The porous polymer substrate may support tissue integration and / or tissue ingrowth in certain applications. The composite material may be used in electrochemical analyte biosensors and other applications.

An external end device has a casing, including a base, in which a distal opening is formed which receives a funnel-shaped septum having a tube trunk. Inside the tube trunk, the catheter is connected to the distal section of the fitting. A tubular coating has a proximal end adapted to be grafted onto the tube trunk and a distal end coaxially adhering to the catheter. A pair of bands of tissue-ingrowth material is fixed on the tubular coating, and an anchor ring, equipped with anchoring means, is sandwiched between the bands.

Disclosed herein are medical devices comprising a single-lobed, thin-walled, expandable body (“ballstent” or “blockstent”) and a flexible, elongated delivery device (“delivery catheter”) and systems and methods of use for treating saccular vascular aneurysms and methods of use for occluding segments of blood vessels and other biological conduits.Expandable bodies comprising gold, platinum, or silver that can be compressed, positioned in the lumen of an aneurysm or blood vessel, and expanded to conform to the shape of the aneurysm or segment of blood vessel or biological conduit are disclosed. The external surface of the expandable bodies can be configured to promote local thrombosis and to promote the growth of tissue into and around the wall in order to reduce migration of the expandable body and to occlude and seal the aneurysm or biological conduit. The wall of the expandable bodies can also be configured to release drugs or pharmacologically active molecules, such as those that promote thrombosis, cell proliferation, extracellular matrix deposition, or tissue ingrowth.

The present disclosure provides tissue products produced from extracellular tissue matrices. The tissue products can include acellular extracellular matrices that have been treated in select areas to increase the compressive modulus of the matrix in the selected area while maintaining the ability to support cell growth and tissue regeneration. In addition, the tissue products can include collagen-containing materials that support tissue ingrowth along with a framework of collagenous or polymeric materials such that the combination has a desired compressive or tensile modulus and / or strength while maintaining the ability to support cell growth and tissue regeneration.